Sadhasivam Subramaniam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sadhasivam Subramaniam has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Becky Robert
Biomaterials and Bioprocess Laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, India
5 shared publicationsDhrisya Chenthamara
Bioprocess and Biomaterials laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, India
5 shared publicationsMurugan Prasathkumar
Biomaterials and Bioprocess Laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore 641046, India; Brodie Tooth Development Genetics & Regenerative Medicine Research Laboratory, Department of Oral Biology, University of Illinois at Chicago, Chicago, IL 60612, USA
5 shared publicationsSankar Ganesh Ramakrishnan
Bioprocess and Biomaterials laboratory, Department of Microbial Biotechnology, Bharathiar University, Coimbatore, India
5 shared publicationsChenthamara Dhrisya
Biomaterials and Bioprocess Laboratory Department of Microbial Biotechnology Bharathiar University Coimbatore 641046 India
3 shared publicationsMuthusaravanan Sivaramakrishnan
Department of Biotechnology, Mepco Schlenk Engineering College, Sivakasi, India
3 shared publications
Latest Publications
Targeting Extracellular Polymeric Substances and Multidrug‐Resistant Bacteria Biofilms Using Zinc Oxide–Enhanced Chitosan/Polyvinyl Alcohol Nanofibers Deposited on Bacterial Cellulose
The rapid emergence of antimicrobial resistance, particularly among multidrug‐resistant bacteria (MDRB) and biofilm‐associated infections, poses a critical public health threat. In this study, a multifunctional nanocomposite with enhanced antibiofilm potential was developed by integrating zinc oxide nanoparticles (ZnO NPs) into a bacterial cellulose (BC)‐based scaffold. ZnO NPs, synthesized via the co‐precipitation method, displayed uniform spherical morphology and were comprehensively characterized using UV–Vis, FTIR, FE‐SEM, EDS, XRD, and DLS analyses. A composite nanofiber matrix was fabricated by electrospinning a chitosan (CS)/polyvinyl alcohol (PVA) blend containing ZnO NPs onto BC, yielding structurally stable BC‐PVA‐CS‐ZnO nanofibers (NFs). Both ZnO NPs and nanofibers exhibited antioxidant activity (30.42% and 34.54%, respectively), and hemocompatibility, confirming their biocompatible nature. Antibacterial studies against Staphylococcus aureus , Escherichia coli , and Pseudomonas aeruginosa revealed significant bacterial inhibition, while biofilm assays demonstrated disruption rates of 29.5% (ZnO NPs) and 24.4% (nanofibers), respectively, against P. aeruginosa . The synergistic integration of ZnO with CS/PVA and BC effectively disrupted extracellular polymeric substances (EPS) and suppressed MDR biofilms. Owing to its structural integrity, biodegradability, and tissue compatibility, the engineered nanocomposite demonstrates strong potential as an alternative to conventional antibiotics for wound management and prevention of biofilm‐related resistant infections.
Targeting Extracellular Polymeric Substances and Multidrug‐Resistant Bacteria Biofilms Using Zinc Oxide–Enhanced Chitosan/Polyvinyl Alcohol Nanofibers Deposited on Bacterial Cellulose
The rapid emergence of antimicrobial resistance, particularly among multidrug‐resistant bacteria (MDRB) and biofilm‐associated infections, poses a critical public health threat. In this study, a multifunctional nanocomposite with enhanced antibiofilm potential was developed by integrating zinc oxide nanoparticles (ZnO NPs) into a bacterial cellulose (BC)‐based scaffold. ZnO NPs, synthesized via the co‐precipitation method, displayed uniform spherical morphology and were comprehensively characterized using UV–Vis, FTIR, FE‐SEM, EDS, XRD, and DLS analyses. A composite nanofiber matrix was fabricated by electrospinning a chitosan (CS)/polyvinyl alcohol (PVA) blend containing ZnO NPs onto BC, yielding structurally stable BC‐PVA‐CS‐ZnO nanofibers (NFs). Both ZnO NPs and nanofibers exhibited antioxidant activity (30.42% and 34.54%, respectively), and hemocompatibility, confirming their biocompatible nature. Antibacterial studies against Staphylococcus aureus , Escherichia coli , and Pseudomonas aeruginosa revealed significant bacterial inhibition, while biofilm assays demonstrated disruption rates of 29.5% (ZnO NPs) and 24.4% (nanofibers), respectively, against P. aeruginosa . The synergistic integration of ZnO with CS/PVA and BC effectively disrupted extracellular polymeric substances (EPS) and suppressed MDR biofilms. Owing to its structural integrity, biodegradability, and tissue compatibility, the engineered nanocomposite demonstrates strong potential as an alternative to conventional antibiotics for wound management and prevention of biofilm‐related resistant infections.
- 23 June 2023
- Published by Wiley in Advanced Materials Technologies
- Vol. 8 (15)
The Design and Developments of Protein‐Polysaccharide Biomaterials for Corneal Tissue Engineering
Corneal blindness is explained by a large reduction in vision loss caused by acute and chronic corneal diseases and/or disorders. Due to the severe unavailability of donor corneas, immune rejection, and the side effects of keratoprosthesis (KPro), vision‐impaired patients are often unable to restore their vision. Corneal tissue engineering appears to be a promising method using natural polymers made from different layers of corneal cells such as epithelium, stroma, and endothelium or full tissue equivalents. Proteins and polysaccharides are able to mimic the chemical composition of the native extracellular matrix (ECM), which has been extensively studied for corneal tissue engineering. Additionally, protein‐based materials are highly favored in corneal regenerative therapy as they have the proper cell‐binding sites for cell adhesion, corneal innervation regeneration, and oxidative stress suppression, while polysaccharide‐based materials can also promote cell proliferation and adhesion as well as ocular permeability. Herein, a comprehensive review of various biomaterials based on natural proteins (fibrin, fibrinogen, silk fibroin, collagen, gelatin, and serum albumin) and polysaccharides (chitin, chitosan, hyaluronic acid, alginate, cellulose, and gellan gum) for corneal tissue engineering are provided. The protein‐polysaccharide biomaterials are mainly used in the form of hydrogels, films, scaffolds, sutures, eye drops, nanocarriers, and nanocapsules to treat ocular diseases that cause blindness, such as corneal wounds, corneal ulcers, Goldenhar syndrome, corneal endothelium and stroma defects, corneal neovascularization, etc. In this review, insight is provided into recent developments in the areas of biomaterial design, cross‐linking strategy, corneal cell selection, and frontiers that are expected to offer researchers support and creativity in the development of corneal regenerative medicine.
- 23 June 2023
- Published by Wiley in Advanced Materials Technologies
- Vol. 8 (15)
The Design and Developments of Protein‐Polysaccharide Biomaterials for Corneal Tissue Engineering
Corneal blindness is explained by a large reduction in vision loss caused by acute and chronic corneal diseases and/or disorders. Due to the severe unavailability of donor corneas, immune rejection, and the side effects of keratoprosthesis (KPro), vision‐impaired patients are often unable to restore their vision. Corneal tissue engineering appears to be a promising method using natural polymers made from different layers of corneal cells such as epithelium, stroma, and endothelium or full tissue equivalents. Proteins and polysaccharides are able to mimic the chemical composition of the native extracellular matrix (ECM), which has been extensively studied for corneal tissue engineering. Additionally, protein‐based materials are highly favored in corneal regenerative therapy as they have the proper cell‐binding sites for cell adhesion, corneal innervation regeneration, and oxidative stress suppression, while polysaccharide‐based materials can also promote cell proliferation and adhesion as well as ocular permeability. Herein, a comprehensive review of various biomaterials based on natural proteins (fibrin, fibrinogen, silk fibroin, collagen, gelatin, and serum albumin) and polysaccharides (chitin, chitosan, hyaluronic acid, alginate, cellulose, and gellan gum) for corneal tissue engineering are provided. The protein‐polysaccharide biomaterials are mainly used in the form of hydrogels, films, scaffolds, sutures, eye drops, nanocarriers, and nanocapsules to treat ocular diseases that cause blindness, such as corneal wounds, corneal ulcers, Goldenhar syndrome, corneal endothelium and stroma defects, corneal neovascularization, etc. In this review, insight is provided into recent developments in the areas of biomaterial design, cross‐linking strategy, corneal cell selection, and frontiers that are expected to offer researchers support and creativity in the development of corneal regenerative medicine.
- Open Access
- 9 December 2022
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 7 (50) , 45849-45866
Gasotransmitter-Induced Therapeutic Angiogenesis: A Biomaterial Prospective
Gasotransmitters such as NO, H2S, and CO have emerged as key players in the regulation of various pathophysiological functions, prompting the development of gas therapy for various pathogeneses. Deficient production of gasotransmitters has been linked to various diseases such as hypertension, endothelial dysfunction, myocardial infarction, ischemia, and impaired wound healing, as they are involved in the regulatory action of angiogenesis. A better understanding of the regulatory mechanisms has given new hope to address the vascular impairment caused by the breakthroughs in gasotransmitters as therapeutics. However, the unstable nature and poor target specificity of gas donors limit the full efficacy of drugs. In this regard, biomaterials that possess excellent biocompatibility and porosity are ideal drug carriers to deliver the gas transmitters in a tunable manner for therapeutic angiogenesis. This review article provides a comprehensive discussion of biomaterial-based gasotransmitter delivery approaches for therapeutic angiogenesis. The critical role of gasotransmitters in modulating angiogenesis during tissue repair as well as their challenges and future directions are demonstrated.
- 9 December 2022
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 7 (50) , 45849-45866
Open AccessGasotransmitter-Induced Therapeutic Angiogenesis: A Biomaterial Prospective
Gasotransmitters such as NO, H2S, and CO have emerged as key players in the regulation of various pathophysiological functions, prompting the development of gas therapy for various pathogeneses. Deficient production of gasotransmitters has been linked to various diseases such as hypertension, endothelial dysfunction, myocardial infarction, ischemia, and impaired wound healing, as they are involved in the regulatory action of angiogenesis. A better understanding of the regulatory mechanisms has given new hope to address the vascular impairment caused by the breakthroughs in gasotransmitters as therapeutics. However, the unstable nature and poor target specificity of gas donors limit the full efficacy of drugs. In this regard, biomaterials that possess excellent biocompatibility and porosity are ideal drug carriers to deliver the gas transmitters in a tunable manner for therapeutic angiogenesis. This review article provides a comprehensive discussion of biomaterial-based gasotransmitter delivery approaches for therapeutic angiogenesis. The critical role of gasotransmitters in modulating angiogenesis during tissue repair as well as their challenges and future directions are demonstrated.
- 10 November 2022
- Published by Springer Nature in 3 Biotech
- Vol. 12 (12) , 1-18
Improved laccase production from Pleurotus floridanus using deoiled microalgal biomass: statistical and hybrid swarm-based neural networks modeling approach
Fungal laccases are versatile biocatalyst and occupy a prominent place in various industrial applications due to its broad substrate specificity. The simplest method to enhance the laccase production is by usage of cheap substrates in the fermentation processes incorporating modeling approaches for optimization. Integrated biorefinery concept is receiving wide popularity by making use of various products from microalgal biomass. The research aimed to identify the potential of deoiled microalgal biomass (DMB), a waste product from algal biorefinery as a nutrient supplement to enhance laccase production in Pleurotus floridanus by submerged fermentation. The maximum production was obtained in the presence of DMB as an additional nutrient supplement and copper sulfate as an inducer. The predictive capabilities of the two methodologies Response Surface Methodology (RSM) and hybrid Particle swarm optimization (PSO)-based Artificial Neural Network (ANN) were compared and validated. The results showed that ANN coupled with PSO predicted with more accuracy with an R2 value of 0.99 than the RSM model with an R2 value of 0.97. The optimized condition as predicted by superior model hybrid PSO-based ANN was glucose (3.51%), DMB (0.545%), pH (4.9), temperature (24.68 ℃) and CuSO4 (1.35 mM). The experimental laccase activity was 80.45 ± 0.132 U/mL which was 1.3 fold higher than unoptimized condition. This study promotes the usage of DMB as a novel supplement for the improved production of Pleurotus floridanus laccase.
- 10 November 2022
- Published by Springer Nature in 3 Biotech
- Vol. 12 (12) , 1-18
Improved laccase production from Pleurotus floridanus using deoiled microalgal biomass: statistical and hybrid swarm-based neural networks modeling approach
Fungal laccases are versatile biocatalyst and occupy a prominent place in various industrial applications due to its broad substrate specificity. The simplest method to enhance the laccase production is by usage of cheap substrates in the fermentation processes incorporating modeling approaches for optimization. Integrated biorefinery concept is receiving wide popularity by making use of various products from microalgal biomass. The research aimed to identify the potential of deoiled microalgal biomass (DMB), a waste product from algal biorefinery as a nutrient supplement to enhance laccase production in Pleurotus floridanus by submerged fermentation. The maximum production was obtained in the presence of DMB as an additional nutrient supplement and copper sulfate as an inducer. The predictive capabilities of the two methodologies Response Surface Methodology (RSM) and hybrid Particle swarm optimization (PSO)-based Artificial Neural Network (ANN) were compared and validated. The results showed that ANN coupled with PSO predicted with more accuracy with an R2 value of 0.99 than the RSM model with an R2 value of 0.97. The optimized condition as predicted by superior model hybrid PSO-based ANN was glucose (3.51%), DMB (0.545%), pH (4.9), temperature (24.68 ℃) and CuSO4 (1.35 mM). The experimental laccase activity was 80.45 ± 0.132 U/mL which was 1.3 fold higher than unoptimized condition. This study promotes the usage of DMB as a novel supplement for the improved production of Pleurotus floridanus laccase.
- 4 February 2022
- Published by Springer Nature in Biotechnology Letters
- Vol. 44 (2) , 203-238
Evaluation of hypoglycemic therapeutics and nutritional supplementation for type 2 diabetes mellitus management: An insight on molecular approaches
Objective This review aims to summarize the current management of type 2 diabetes principles, including oral hypoglycemic agents, types of insulin administration, diet maintenance, and various molecular approaches. Methods A literature search was conducted in different databases such as Scopus, ScienceDirect, Google Scholar, and Web of Science by using the following keywords: type-2 diabetes mellitus (T2DM), first-line and second-line treatment, oral hypoglycemic agents, insulin administration, diet/nutritional therapy, gene and stem cell therapy, and diabetic complications. Results The first-line treatment of T2DM includes administering oral hypoglycemic agents (OHAs) and second-line treatment by insulin therapy and some OHAs like Sulfonylurea’s (SU). The oral hypoglycemic or oral antidiabetic drugs have the function of lowering glucose in the blood. Insulin therapy is recommended for people with A1C levels > 7.0, and insulin administration is evolved drastically from the syringe, pump, pen, inhalation, insulin jet, and patch. The use of OHAs and insulin therapy during glycemic control has a severe effect on weight gain and other side effects. Hence, diet maintenance (macro and micronutrients) and nutritional therapy guidelines were also reviewed/recommended for safe T2DM management. Besides, the recent progress in molecular approaches that focuses on identifying new targets for T2DM (i.e.) consisting of gene therapy, stem cell therapy, and the modulation of insulin signaling pathways for the regulation of glucose storage and uptake also discussed. Conclusion The analysis of all these key factors is necessary to develop a potential agent to cure T2DM and suggest that a combination of therapies will pave the way for advanced management of T2DM.
- 4 February 2022
- Published by Springer Nature in Biotechnology Letters
- Vol. 44 (2) , 203-238
Evaluation of hypoglycemic therapeutics and nutritional supplementation for type 2 diabetes mellitus management: An insight on molecular approaches
Objective This review aims to summarize the current management of type 2 diabetes principles, including oral hypoglycemic agents, types of insulin administration, diet maintenance, and various molecular approaches. Methods A literature search was conducted in different databases such as Scopus, ScienceDirect, Google Scholar, and Web of Science by using the following keywords: type-2 diabetes mellitus (T2DM), first-line and second-line treatment, oral hypoglycemic agents, insulin administration, diet/nutritional therapy, gene and stem cell therapy, and diabetic complications. Results The first-line treatment of T2DM includes administering oral hypoglycemic agents (OHAs) and second-line treatment by insulin therapy and some OHAs like Sulfonylurea’s (SU). The oral hypoglycemic or oral antidiabetic drugs have the function of lowering glucose in the blood. Insulin therapy is recommended for people with A1C levels > 7.0, and insulin administration is evolved drastically from the syringe, pump, pen, inhalation, insulin jet, and patch. The use of OHAs and insulin therapy during glycemic control has a severe effect on weight gain and other side effects. Hence, diet maintenance (macro and micronutrients) and nutritional therapy guidelines were also reviewed/recommended for safe T2DM management. Besides, the recent progress in molecular approaches that focuses on identifying new targets for T2DM (i.e.) consisting of gene therapy, stem cell therapy, and the modulation of insulin signaling pathways for the regulation of glucose storage and uptake also discussed. Conclusion The analysis of all these key factors is necessary to develop a potential agent to cure T2DM and suggest that a combination of therapies will pave the way for advanced management of T2DM.
- Open Access
- 4 February 2022
- Published by CMB Association in Cellular and Molecular Biology
- Vol. 67 (5) , 439-450
Diclofenac biotransformation and toxicity assessment of laccase from Pleurotus floridanus
Laccase producing fungus Pleurotus floridanus was isolated from Siruvani forest, Tamil Nadu, India. The potential of P. floridanus to produce laccase by using various lignocellulosic substrates was screened under submerged fermentation. Laccase production in the presence of lignocellulosic substrates such as rice, wheat and maize bran as a sole source of carbon as well as an additional supplement was examined. Laccase activity of P. floridanus using varied substrates was observed in the order of rice bran > wheat bran > maize bran. The isolate showed maximum laccase activity of 13.29±0.01 U/mL using rice bran as a carbon source within 11 days. This was 18 fold higher than the control media that lacks lignocellulosic substrates. The diclofenac tolerance was assessed in solid media at various concentrations and the results showed that the mycelia growth is not significantly affected by the drug. Finally, the laccase mediated degradation of diclofenac at a concentration of 10 mg/L showed 98% degradation in 2 h. The phytotoxicity of the crude laccase treated diclofenac was lower than the untreated diclofenac. In conclusion, findings suggested direct application of crude laccase produced from P. floridanus using agro-residues as ideal substrate for environmental applications.
- 4 February 2022
- Published by CMB Association in Cellular and Molecular Biology
- Vol. 67 (5) , 439-450
Open AccessDiclofenac biotransformation and toxicity assessment of laccase from Pleurotus floridanus
Laccase producing fungus Pleurotus floridanus was isolated from Siruvani forest, Tamil Nadu, India. The potential of P. floridanus to produce laccase by using various lignocellulosic substrates was screened under submerged fermentation. Laccase production in the presence of lignocellulosic substrates such as rice, wheat and maize bran as a sole source of carbon as well as an additional supplement was examined. Laccase activity of P. floridanus using varied substrates was observed in the order of rice bran > wheat bran > maize bran. The isolate showed maximum laccase activity of 13.29±0.01 U/mL using rice bran as a carbon source within 11 days. This was 18 fold higher than the control media that lacks lignocellulosic substrates. The diclofenac tolerance was assessed in solid media at various concentrations and the results showed that the mycelia growth is not significantly affected by the drug. Finally, the laccase mediated degradation of diclofenac at a concentration of 10 mg/L showed 98% degradation in 2 h. The phytotoxicity of the crude laccase treated diclofenac was lower than the untreated diclofenac. In conclusion, findings suggested direct application of crude laccase produced from P. floridanus using agro-residues as ideal substrate for environmental applications.